Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Frontiers in Parasitology|August 14, 2025
Guanine derivatives as promising candidates for the development of purine-based antimalarial drugsWorlanyo Tashie, Harry P de Koning, Nancy O Duah-Quashie, et al.
International Journal for Parasitology|December 19, 2025
Genetic diversity of Plasmodium falciparum equilibrative nucleoside transporters PfENT1 and PfENT4: Implications for purine-based antimalarial drug developmentWorlanyo Tashie, Harry P de Koning, Nancy O Duah-Quashie, et al.
Pathogens (Basel, Switzerland)|March 28, 2026
Identification of TgENT1 as the TgUUT1 Uracil/Uridine Transporter of <i>Toxoplasma gondii</i>Hamza A A Elati, Mariana Ferreira Silva, Lilach Sheiner, et al.
Medical Science Educator|October 24, 2022
Increasing Collaborative Discussion in Case-Based Learning Improves Student Engagement and Knowledge AcquisitionNana Sartania, Sharon Sneddon, James G Boyle, et al.
Frontiers in Microbiology|April 2, 2026
Targeting <i>Plasmodium falciparum</i> with purine antimetabolites as a therapeutic strategyWorlanyo Tashie, Harry P de Koning, Nancy O Duah-Quashie, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 12, 2026
Screening of purine nucleoside analogues against intracellular Toxoplasma gondiiHamza A A Elati, Serge Van Calenbergh, Lilach Sheiner, et al.
International Journal for Parasitology. Drugs and Drug Resistance|March 6, 2014
Trypanosoma brucei adenine-phosphoribosyltransferases mediate adenine salvage and aminopurinol susceptibility but not adenine toxicityAlexandra Lüscher, Estelle Lamprea-Burgunder, Fabrice E Graf, et al.
Scientific Reports|March 17, 2018
Multi-target mode of action of a Clerodane-type diterpenoid from Polyalthia longifolia targeting African trypanosomesGodwin U Ebiloma, Evangelos Katsoulis, John O Igoli, et al.
Parasitology|October 11, 2016
The animal trypanosomiases and their chemotherapy: a reviewFederica Giordani, Liam J Morrison, Tim G Rowan, et al.
International Journal for Parasitology. Drugs and Drug Resistance|January 28, 2019
The individual components of commercial isometamidium do not possess stronger trypanocidal activity than the mixture, nor bypass isometamidium resistanceAnthonius A Eze, John Igoli, Alexander I Gray, et al.
Pageof 18